loadpatents
name:-0.031224012374878
name:-0.010493040084839
name:-0.0060250759124756
Irving; Bryan Patent Filings

Irving; Bryan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Irving; Bryan.The latest application filed is for "methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors".

Company Profile
5.9.30
  • Irving; Bryan - San Francisco CA
  • IRVING; Bryan - South San Francisco CA
  • IRVING; Bryan - San Francsicso CA
  • Irving; Bryan - Woodside CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors
App 20210340253 - Grogan; Jane ;   et al.
2021-11-04
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors
App 20210332132 - Grogan; Jane ;   et al.
2021-10-28
Anti-pd-l1 Antibodies, Compositions And Articles Of Manufacture
App 20210032345 - IRVING; Bryan ;   et al.
2021-02-04
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors
App 20200399366 - GROGAN; Jane ;   et al.
2020-12-24
Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors
Grant 10,646,567 - Maecker , et al.
2020-05-12
Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors
Grant 10,626,174 - Grogan , et al.
2020-04-21
Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors
Grant 10,611,836 - Grogan , et al.
2020-04-07
Anti-pd-l1 Antibodies, Compositions And Articles Of Manufacture
App 20190016807 - IRVING; Bryan ;   et al.
2019-01-17
Methods Of Treating Cancer Using Pd-l1 Axis Binding Antagonists And Vegf Antagonists
App 20180236066 - MAECKER; Heather ;   et al.
2018-08-23
Anti-PD-L1 antibodies, compositions and articles of manufacture
Grant 9,920,123 - Irving , et al. March 20, 2
2018-03-20
Methods of treating cancer using PD-L1 axis binding antagonists and VEGF antagonists
Grant 9,895,441 - Maecker , et al. February 20, 2
2018-02-20
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
App 20180021431 - MAECKER; Heather ;   et al.
2018-01-25
Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors
Grant 9,873,740 - Grogan , et al. January 23, 2
2018-01-23
Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors
Grant 9,724,413 - Maecker , et al. August 8, 2
2017-08-08
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function To Treat Tumor Immunity
App 20170107287 - IRVING; Bryan ;   et al.
2017-04-20
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors
App 20170044256 - GROGAN; Jane ;   et al.
2017-02-16
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors
App 20170037127 - GROGAN; Jane ;   et al.
2017-02-09
Methods Of Treating Her2-positive Cancers Using Pd-1 Axis Binding Antagonists And Anti-her2 Antibodies
App 20170008971 - DENNIS; Mark S. ;   et al.
2017-01-12
Nucleic Acid Encoding Anti-pd-l1 Antibodies
App 20160222117 - IRVING; Bryan ;   et al.
2016-08-04
Methods Of Treating Cancer Using Pd-l1 Axis Binding Antagonists And Vegf Antagonists
App 20150320859 - MAECKER; Heather ;   et al.
2015-11-12
Anti-pd-l1 Antibodies And Articles Of Manufacture
App 20150322153 - IRVING; Bryan ;   et al.
2015-11-12
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors
App 20150216970 - GROGAN; Jane ;   et al.
2015-08-06
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
App 20140341902 - Maecker; Heather ;   et al.
2014-11-20
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function To Treat Tumor Immunity
App 20140065135 - Irving; Bryan ;   et al.
2014-03-06
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Treat Infection Resulting From T-cell Dysfunction
App 20130045200 - Irving; Bryan ;   et al.
2013-02-21
Anti-pd-l1 Antibodies And Articles Of Manufacture
App 20130045202 - Irving; Bryan ;   et al.
2013-02-21
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function To Treat Tumor Immunity
App 20130045201 - IRVING; BRYAN ;   et al.
2013-02-21
Anti-PD-L1 antibodies, compositions and articles of manufacture
Grant 8,217,149 - Irving , et al. July 10, 2
2012-07-10
Novel Gene Disruptions, Compositions And Methods Relating Thereto
App 20110182883 - Combs; Katherin E. ;   et al.
2011-07-28
Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function
App 20100203056 - Irving; Bryan ;   et al.
2010-08-12
Novel Gene Disruptions, Compositions and Methods Relating Thereto
App 20090293137 - Combs; Katherin E. ;   et al.
2009-11-26
Novel Gene Disruptions, Composition and Methods Relating Thereto
App 20080305106 - Brennan; Jane ;   et al.
2008-12-11
Methods of treating lupus using CD4 antibodies
App 20080279848 - Irving; Bryan
2008-11-13
Methods of treating lupus using CD4 antibodies
App 20070218062 - Irving; Bryan
2007-09-20
Company Registrations
SEC0001715542Irving Bryan

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed